EphB4 was targeted by Xiong et al. using the TNYL-RAW peptide radiolabeled with [64Cu]Cu-DOTA, yielding specific tumor uptake in EphB4-positive models [180]. The gene discussed is EPHB4; the disease is neoplasm.